3-(1-(4-Methoxyphenyl)-3-methyl-1H-pyrazolo[3,4-d]thiazol-5-yl)cyclohexanecarboxylic acid

Catalog No. :
ACFKNO268
CAS No. :
1172372-71-2
Molecular Formula :
C19H21N3O3S
Molecular Weight :
371.46

IUPAC Name:3-(1-(4-methoxyphenyl)-3-methyl-1H-pyrazolo[3,4-d]thiazol-5-yl)cyclohexane-1-carboxylic acid

3-(1-(4-Methoxyphenyl)-3-methyl-1H-pyrazolo[3,4-d]thiazol-5-yl)cyclohexanecarboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(1-(4-Methoxyphenyl)-3-methyl-1H-pyrazolo[3,4-d]thiazol-5-yl)cyclohexanecarboxylic acid
IUPAC Name3-(1-(4-methoxyphenyl)-3-methyl-1H-pyrazolo[3,4-d]thiazol-5-yl)cyclohexane-1-carboxylic acid
MDL No.MFCD14281823
Molecular FormulaC19H21N3O3S
Molecular Weight371.46
SMILESO=C(C1CC(C2=NC(N(C3=CC=C(OC)C=C3)N=C4C)=C4S2)CCC1)O
InChI KeyIXVBQRMTQVQOBH-UHFFFAOYSA-N
Synonym3-[1-(4-Methoxyphenyl)-3-methyl-1H-pyrazolo-[3,4-d][1,3]thiazol-5-yl]cyclohexanecarboxylic acid;3-[1-(4-Methoxyphenyl)-3-methyl-1H-pyrazolo-[3,4-d][1,3]thiazol-5-yl]cyclohexanecarboxylic aci;Cyclohexanecarboxylic acid, 3-[1-(4-methoxyphenyl)-3-methyl-1H-pyrazolo[3,4-d]thiazol-5-yl]-
CAS No.1172372-71-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACFKNO268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFKNO268 route product structure diagram
    ACFKNO2681172372-71-2
Inquiry

2. ACFKNO268 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFKNO268 route product structure diagram
    ACFKNO2681172372-71-2
Inquiry

Comments (0)